Insights from the molecular docking analysis of colistin with the PmrA protein model from Acinetobacter baumannii.
| Autor: | Ganeshan S; Department of Biotechnology, Tips college of arts and science, Coimbatore, Tamil Nadu 641107, India., Shakibaie MR; Department of Microbiology and Virology, Kerman University of Medical Sciences, Kerman, Iran.; Environmental Health Engineering Research Center, Kerman University of Medical Science, Kerman, Iran., Rajagopal R; Research Scholar Department of Pharmaceutics, Mother Theresa Post Graduate and Research Institute of Health Sciences, Pondicherry-605006, India. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Bioinformation [Bioinformation] 2022 Jan 31; Vol. 18 (1), pp. 41-49. Date of Electronic Publication: 2022 Jan 31 (Print Publication: 2022). |
| DOI: | 10.6026/97320630018041 |
| Abstrakt: | Acinetobacter baumannii (AB) is one of the most common causes of nosocomial infections. Therefore, it is of interest to design and develop drugs against Acinetobacter baumannii. A strain of AB showing MIC 32 µg/ml against colistin was isolated from a hospital environment in Iran. Hence, we document data to glean insights from the molecular docking analysis of colistin with the PmrA protein from this bacterium. Competing Interests: The authors declare no competing financial interests. (© 2022 Biomedical Informatics.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|